{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:36:09Z","timestamp":1791894969109,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007343","name":"Universit\u00e0 degli Studi di Brescia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Ultrasound-guided thermal ablation (U-GTA) techniques, including radiofrequency ablation (RFA) and microwave ablation (MWA), have recently been proposed as minimally invasive alternatives to surgery or radioiodine (RAI) therapy for patients with Graves\u2019 disease (GD) who are unresponsive to antithyroid drugs. However, evidence supporting its effectiveness and safety remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A PubMed\/MEDLINE, Web of Science, and Scopus research updated until January 31, 2026, was performed. The review question was: What is the euthyroidism rate (outcome) one year after U-GTA (intervention) in Graves\u2019 disease (population)? Two reviewers independently conducted the study screening, data extraction, and risk of bias assessment. A random-effects model was adopted to pool the prevalence with corresponding 95% confidence intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four studies comprising 82 patients (88% female) were included in the analysis. Approximately 2.4% of patients required levothyroxine replacement after U-GTA. Thyroid volume significantly decreased following treatment, and baseline thyroid volume was identified as a predictor of relapse in one study. A transient increase in anti-TSH receptor antibodies was observed one month after U-GTA, followed by a subsequent decline. No worsening or new onset of Graves\u2019 orbitopathy was reported. Post-procedural adverse events occurred in 6.1% of patients and were transient. At 12 months, pooled euthyroidism rate was 67.0% (95% CI 54\u201378), with low heterogeneity (I\u00b2 = 0%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>U-GTA appears to induce biochemical remission in approximately two-thirds of selected patients with persistent or relapsed GD, with a favourable short-term safety profile and preservation of thyroid function in most cases. However, remission rates remain lower than those typically reported for definitive surgical treatment, and current evidence is limited to small, non-randomized studies with relatively short follow-up. Larger prospective comparative trials with standardized protocols are required to define the role of U-GTA within current management strategies for GD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-026-04740-2","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:07:12Z","timestamp":1786190832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ultrasound-guided thermal ablation in patients affected by Graves\u2019 disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"91","author":[{"given":"Elisa","family":"Gatta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Casella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rotondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-1232","authenticated-orcid":false,"given":"Carlo","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"issue":"6","key":"4740_CR1","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1148\/rg.220021","volume":"42","author":"PJ Navin","year":"2022","unstructured":"P.J. Navin, S.M. Thompson, A.N. Kurup, R.A. Lee, M.R. Callstrom, M.R. Castro, M.N. Stan, B.T. Welch, J.J. Schmitz, Radiofrequency Ablation of Benign and Malignant Thyroid Nodules. Radiographics. 42(6), 1812\u20131828 (2022). https:\/\/doi.org\/10.1148\/rg.220021","journal-title":"Radiographics"},{"issue":"10","key":"4740_CR2","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.21037\/gs-24-221","volume":"13","author":"X Luo","year":"2024","unstructured":"X. Luo, E. Kandil, Microwave ablation: a technical and clinical comparison to other thermal ablation modalities to treat benign and malignant thyroid nodules. Gland Surg. 13(10), 1805\u20131813 (2024). https:\/\/doi.org\/10.21037\/gs-24-221","journal-title":"Gland Surg."},{"issue":"4","key":"4740_CR3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3348\/kjr.2018.19.4.632","volume":"19","author":"JH Kim","year":"2018","unstructured":"J.H. Kim, J.H. Baek, H.K. Lim, H.S. Ahn, S.M. Baek, Y.J. Choi, Y.J. Choi, S.R. Chung, E.J. Ha, S.Y. Hahn et al., 2017 thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J. Radiol. 19(4), 632\u2013655 (2018). https:\/\/doi.org\/10.3348\/kjr.2018.19.4.632","journal-title":"Korean J. Radiol."},{"issue":"3","key":"4740_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/cen.14857","volume":"98","author":"Z Chen","year":"2023","unstructured":"Z. Chen, W. Zhang, W. He, Ultrasound-guided thermal ablation for papillary thyroid microcarcinoma: A systematic review. Clin. Endocrinol. (Oxf). 98(3), 296\u2013305 (2023). https:\/\/doi.org\/10.1111\/cen.14857","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"4740_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12020-025-04519-x","volume":"91","author":"E Gatta","year":"2026","unstructured":"E. Gatta, C. Cappelli, R. Negro, Radiofrequency and microwave versus surgery for the treatment of Less-than-1-cm papillary thyroid carcinoma: a systematic review and Meta-Analysis. Endocrine. 91(1), 27 (2026). https:\/\/doi.org\/10.1007\/s12020-025-04519-x","journal-title":"Endocrine"},{"issue":"1\u20133","key":"4740_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12026-009-8153-2","volume":"47","author":"WW Eaton","year":"2010","unstructured":"W.W. Eaton, M.G. Pedersen, H.O. Atlad\u00f3ttir, P.E. Gregory, N.R. Rose, P.B. Mortensen, The prevalence of 30 ICD-10 autoimmune diseases in Denmark. Immunol. Res. 47(1\u20133), 228\u2013231 (2010). https:\/\/doi.org\/10.1007\/s12026-009-8153-2","journal-title":"Immunol. Res."},{"issue":"16","key":"4740_CR7","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"T.J. Smith, L. Heged\u00fcs, Graves\u2019 Disease. N Engl. J. Med. 375(16), 1552\u20131565 (2016). https:\/\/doi.org\/10.1056\/NEJMra1510030","journal-title":"N Engl. J. Med."},{"issue":"2","key":"4740_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","volume":"42","author":"DS McLeod","year":"2012","unstructured":"D.S. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine. 42(2), 252\u2013265 (2012). https:\/\/doi.org\/10.1007\/s12020-012-9703-2","journal-title":"Endocrine"},{"issue":"5","key":"4740_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"P.N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-Buey, J.H. Lazarus, C.M. Dayan, O.E. Okosieme, Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14(5), 301\u2013316 (2018). https:\/\/doi.org\/10.1038\/nrendo.2018.18","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"4740_CR10","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1210\/jc.2013-1954","volume":"98","author":"V Sundaresh","year":"2013","unstructured":"V. Sundaresh, J.P. Brito, Z. Wang, L.J. Prokop, M.N. Stan, M.H. Murad, R.S. Bahn, Comparative effectiveness of therapies for Graves\u2019 hyperthyroidism: a systematic review and network meta-analysis. J. Clin. Endocrinol. Metab. 98(9), 3671\u20133677 (2013). https:\/\/doi.org\/10.1210\/jc.2013-1954","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4740_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 372, n71 (2021). https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"Bmj"},{"issue":"9","key":"4740_CR12","doi-asserted-by":"publisher","first-page":"6534","DOI":"10.1007\/s00330-023-09620-1","volume":"33","author":"MHM Fung","year":"2023","unstructured":"M.H.M. Fung, B.H.H. Lang, Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent\/relapsed Graves\u2019 disease, a pilot study. Eur. Radiol. 33(9), 6534\u20136544 (2023). https:\/\/doi.org\/10.1007\/s00330-023-09620-1","journal-title":"Eur. Radiol."},{"key":"4740_CR13","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2024.0177","author":"MHM Fung","year":"2024","unstructured":"M.H.M. Fung, Y. Luk, K.K.W. Yuen, B.H.H. Lang, The Two-Year Results of Using Radiofrequency Ablation as a Novel Treatment for Persistent or Relapsed Graves\u2019 Disease: A Prospective Study. Thyroid. (2024). https:\/\/doi.org\/10.1089\/thy.2024.0177","journal-title":"Thyroid"},{"issue":"1","key":"4740_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13044-024-00198-4","volume":"17","author":"G Cai","year":"2024","unstructured":"G. Cai, B. Luo, M. Wang, J. Su, L. Lin, G. Li, X. Chen, Z. Huang, P. Lin, S. Liu, H. Yan, L. Zhou, Efficacy and safety of ultrasound-guided thermal ablation of graves\u2019 disease: a retrospective cohort study. Thyroid Res. 17(1), 10 (2024). https:\/\/doi.org\/10.1186\/s13044-024-00198-4","journal-title":"Thyroid Res."},{"issue":"1","key":"4740_CR15","doi-asserted-by":"publisher","first-page":"2424903","DOI":"10.1080\/02656736.2024.2424903","volume":"41","author":"JE Zhu","year":"2024","unstructured":"J.E. Zhu, C.J. Sheng, H.L. Zhang, J.X. Li, X.W. Bo, J.J. Yin, P. Yang, S.Y. Yu, L.P. Sun, Ultrasound-guided percutaneous microwave ablation of primary hyperthyroidism: security and efficacy analysis. Int. J. Hyperth. 41(1), 2424903 (2024). https:\/\/doi.org\/10.1080\/02656736.2024.2424903","journal-title":"Int. J. Hyperth."},{"issue":"10","key":"4740_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"D.S. Ross, H.B. Burch, D.S. Cooper, M.C. Greenlee, P. Laurberg, A.L. Maia, S.A. Rivkees, M. Samuels, J.A. Sosa, M.N. Stan et al., 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 26(10), 1343\u20131421 (2016). https:\/\/doi.org\/10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"issue":"11","key":"4740_CR17","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1089\/thy.2005.15.1279","volume":"15","author":"M Abraham-Nordling","year":"2005","unstructured":"M. Abraham-Nordling, O. T\u00f6rring, B. Hamberger, G. Lundell, L. Tallstedt, J. Calissendorff, G. Wallin, Graves\u2019 disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid. 15(11), 1279\u20131286 (2005). https:\/\/doi.org\/10.1089\/thy.2005.15.1279","journal-title":"Thyroid"},{"issue":"4","key":"4740_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"G.J. Kahaly, L. Bartalena, L. Heged\u00fcs, L. Leenhardt, K. Poppe, S.H. Pearce, 2018 European Thyroid Association Guideline for the Management of Graves\u2019 Hyperthyroidism. Eur. Thyroid J. 7(4), 167\u2013186 (2018). https:\/\/doi.org\/10.1159\/000490384","journal-title":"Eur. Thyroid J."},{"issue":"9","key":"4740_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra042972","volume":"352","author":"DS Cooper","year":"2005","unstructured":"D.S. Cooper, Antithyroid drugs. N Engl. J. Med. 352(9), 905\u2013917 (2005). https:\/\/doi.org\/10.1056\/NEJMra042972","journal-title":"N Engl. J. Med."},{"issue":"5","key":"4740_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1089\/thy.2015.0439","volume":"26","author":"J Yang","year":"2016","unstructured":"J. Yang, Y.J. Zhu, J.J. Zhong, J. Zhang, W.W. Weng, Z.F. Liu, Q. Xu, M.J. Dong, Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years. Thyroid. 26(5), 627\u2013633 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0439","journal-title":"Thyroid"},{"issue":"12","key":"4740_CR21","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1210\/jc.2013-2569","volume":"98","author":"H Nakamura","year":"2013","unstructured":"H. Nakamura, A. Miyauchi, N. Miyawaki, J. Imagawa, Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J. Clin. Endocrinol. Metab. 98(12), 4776\u20134783 (2013). https:\/\/doi.org\/10.1210\/jc.2013-2569","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4740_CR22","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1245\/s10434-012-2606-x","volume":"20","author":"BM Genovese","year":"2013","unstructured":"B.M. Genovese, S.I. Noureldine, E.M. Gleeson, R.P. Tufano, E. Kandil, What is the best definitive treatment for Graves\u2019 disease? A systematic review of the existing literature. Ann. Surg. Oncol. 20(2), 660\u2013667 (2013). https:\/\/doi.org\/10.1245\/s10434-012-2606-x","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"4740_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00268-003-6903-1","volume":"28","author":"L Rosato","year":"2004","unstructured":"L. Rosato, N. Avenia, P. Bernante, De M. Palma, G. Gulino, P.G. Nasi, M.R. Pelizzo, L. Pezzullo, Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J. Surg. 28(3), 271\u2013276 (2004). https:\/\/doi.org\/10.1007\/s00268-003-6903-1","journal-title":"World J. Surg."},{"issue":"6","key":"4740_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/er.2012-1030","volume":"33","author":"SJ Bonnema","year":"2012","unstructured":"S.J. Bonnema, L. Heged\u00fcs, Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr. Rev. 33(6), 920\u2013980 (2012). 10.1210\/er.2012\u2009\u2013\u20091030","journal-title":"Endocr. Rev."},{"issue":"6","key":"4740_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1365-2796.1995.tb01230.x","volume":"238","author":"B Nygaard","year":"1995","unstructured":"B. Nygaard, L. Heged\u00fcs, M. Gervil, H. Hjalgrim, B.M. Hansen, P. S\u00f8e-Jensen, J.M. Hansen, Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves\u2019 disease. J. Intern. Med. 238(6), 491\u2013497 (1995). https:\/\/doi.org\/10.1111\/j.1365-2796.1995.tb01230.x","journal-title":"J. Intern. Med."},{"issue":"5","key":"4740_CR26","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.eprac.2023.03.222","volume":"29","author":"DP Suravajjala","year":"2023","unstructured":"D.P. Suravajjala, P. Velumani, B. Rangaswamy, Abstract# 1402013: Relapse of Graves Disease 15 Years After Hypothyroid Phase with Radioactive Iodine. Endocr. Pract. 29(5), S100 (2023)","journal-title":"Endocr. Pract."},{"issue":"3","key":"4740_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2265.2008.03222.x","volume":"69","author":"AM Sawka","year":"2008","unstructured":"A.M. Sawka, D.C. Lakra, J. Lea, B. Alshehri, R.W. Tsang, J.D. Brierley, S. Straus, L. Thabane, A. Gafni, S. Ezzat et al., A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin. Endocrinol. (Oxf). 69(3), 479\u2013490 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03222.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"4740_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1530\/eje-20-0562","volume":"184","author":"H Jin","year":"2021","unstructured":"H. Jin, W. Lin, L. Lu, M. Cui, Conventional thyroidectomy vs thyroid thermal ablation on postoperative quality of life and satisfaction for patients with benign thyroid nodules. Eur. J. Endocrinol. 184(1), 131\u2013141 (2021). https:\/\/doi.org\/10.1530\/eje-20-0562","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"4740_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1507\/endocrj.EJ18-0324","volume":"66","author":"K Sugino","year":"2019","unstructured":"K. Sugino, M. Nagahama, W. Kitagawa, K. Ohkuwa, T. Uruno, K. Matsuzu, A. Suzuki, C. Tomoda, K.Y.H. Akaishi, J. Masaki, C. Ogimi, Y. Yabuta, T. Ito, Change of surgical strategy for Graves\u2019 disease from subtotal thyroidectomy to total thyroidectomy: a single institutional experience. Endocr. J. 66(2), 181\u2013186 (2019). https:\/\/doi.org\/10.1507\/endocrj.EJ18-0324","journal-title":"Endocr. J."},{"issue":"2","key":"4740_CR30","first-page":"103","volume":"10","author":"SA Lui","year":"2007","unstructured":"S.A. Lui, J.L. Teh, Y.X. Gwee, C. Tay, J. Hu, K.Y. Ngiam, C.T. Tan, A. Rauff, W.B. Tan, W.K. Cheah, Surgical management of Graves\u2019 disease over a 25-year period in a single institution: Comparison of outcomes between subtotal thyroidectomy and total thyroidectomy. World J. Endocr. Surg. 10(2), 103\u2013107 (2007)","journal-title":"World J. Endocr. Surg."},{"issue":"6","key":"4740_CR31","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/s0039-6060(96)80049-3","volume":"120","author":"P Miccoli","year":"1996","unstructured":"P. Miccoli, P. Vitti, T. Rago, P. Iacconi, L. Bartalena, F. Bogazzi, E. Fiore, R. Valeriano, L. Chiovato, R. Rocchi et al., Surgical treatment of Graves\u2019 disease: subtotal or total thyroidectomy? Surgery. 120(6):1020-1024 (1996); discussion 4\u20135. https:\/\/doi.org\/10.1016\/s0039-6060(96)80049-3","journal-title":"Surgery"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04740-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04740-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04740-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:07:13Z","timestamp":1786190833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04740-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4740"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04740-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"265"}}